vTv Therapeutics Inc. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/16570964-19b6-4121-a4c7-d018ccc4e9ae/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $0 | 2025-01-01 – 2025-12-31 | evidence 0001641489-26-000010 |
| FY 2024 | $1.0M | 2024-01-01 – 2024-12-31 | evidence 0001641489-25-000014 |
| FY 2023 | $0 | 2023-01-01 – 2023-12-31 | evidence 0001641489-24-000012 |
| FY 2022 | $2.0M | 2022-01-01 – 2022-12-31 | evidence 0001641489-23-000008 |
| FY 2021 | $4.0M | 2021-01-01 – 2021-12-31 | evidence 0001564590-22-012258 |
| FY 2020 | $6.4M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-008149 |
| FY 2019 | $2.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-005627 |
| FY 2018 | $12.4M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-004516 |
| FY 2017 | $291.0k | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-004516 |
| FY 2016 | $634.0k | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-004516 |
| FY 2015 | $519.0k | 2015-01-01 – 2015-12-31 | evidence 0001564590-16-014035 |
| FY 2014 | $1.5M | 2014-01-01 – 2014-12-31 | evidence 0001564590-16-014035 |
| FY 2013 | $976.0k | 2013-01-01 – 2013-12-31 | evidence 0001564590-16-014035 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
vTv Therapeutics Inc. — all facts · Net Income · Operating Income